Skip to main content
Nureca Limited logo

Nureca Limited — Investor Relations & Filings

Ticker · NURECA ISIN · INE0DSF01015 LEI · 894500NRGNYR07CDBN26 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 302 across all filing types
Latest filing 2023-02-05 Regulatory Filings
Country IN India
Listing BSE.NS NURECA

About Nureca Limited

https://www.nureca.com

Nureca Limited specializes in the development and distribution of home healthcare devices and lifestyle products. The company operates through several key brands, most notably Dr Trust, Dr Physio, and Trumom. Its product portfolio includes medical diagnostic tools such as blood pressure monitors, pulse oximeters, nebulizers, and thermometers, as well as wellness equipment like massagers and personal scales. Nureca utilizes a digital-first business model, prioritizing e-commerce channels to provide consumers with accessible medical technology. The company focuses on integrating clinical-grade accuracy with user-centric design to support chronic disease management, fitness tracking, and maternal care. By offering a diverse range of health monitoring solutions, Nureca aims to empower individuals to manage their well-being through proactive and data-driven home-based care.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document contains a newspaper advertisement pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It specifically mentions the publication of unaudited financial results for the quarter and nine months ended December 31, 2022. The text includes references to the financial results being published in newspapers and provides details about the publication and compliance with regulatory requirements. There is no indication that this document contains the full financial report itself; rather, it is an announcement of the publication of financial results. The document length is about 15,000 characters, but the content is primarily an announcement of the newspaper advertisement of financial results, not the full report or detailed financial statements. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Regulatory Filing (RNS) because it is a regulatory announcement of financial results publication, not the report itself.
2023-02-05 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is dated February 3, 2023, and contains unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2022. It includes detailed financial tables with revenues, expenses, profit/loss, and earnings per share. The document also contains a limited review report from the statutory auditors (B S R & Co. LLP) on these unaudited financial results, which is typical for interim or quarterly financial reporting. The presence of unaudited quarterly and nine-month financial results, along with a limited review report, indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long and contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-02-03 English
Financial Result Updates
Interim / Quarterly Report Classification · 100% confidence The document is dated February 3, 2023, and contains unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2022. It includes detailed financial tables with revenues, expenses, profit/loss, and earnings per share. The document also contains a limited review report from the statutory auditors (B S R & Co. LLP) on these unaudited financial results, referencing compliance with Indian Accounting Standard 34 (Interim Financial Reporting) and SEBI Listing Regulations. The presence of quarterly and nine-month financial data, along with auditor limited review, indicates this is an Interim / Quarterly Report. The document is about 15,000 characters, which is substantive and contains actual financial data, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR).
2023-02-03 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notice from Nureca Limited announcing a Board Meeting scheduled for February 3, 2023, to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2022. It is a short announcement informing the stock exchanges and public about the upcoming board meeting and the agenda related to financial results approval. There is no actual financial data or detailed report included, only a notification of the meeting. According to the classification rules, such notices about board meetings to approve financial results fall under Regulatory Filings (RNS) as they are general regulatory announcements and do not contain the financial report itself.
2023-01-27 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice from Nureca Limited informing the stock exchanges about the closure of the trading window for insiders due to the upcoming declaration of unaudited financial results for the period ended December 31, 2022. It is a regulatory announcement related to insider trading compliance and trading restrictions, not a financial report or earnings release itself. The document is short (1510 characters) and serves as an official notification to the exchanges. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-12-31 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter from Nureca Limited to the National Stock Exchange of India addressing a query about an increase in trading volume. It clarifies that there is no pending price sensitive information or announcement related to the company's operations or performance. The letter emphasizes compliance with SEBI regulations and provides a description of the company's business and product categories. There are no financial statements, earnings data, or detailed report content. The document is a regulatory communication clarifying market activity and compliance, not a financial report or announcement of a report. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance communication.
2022-12-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.